Itraconazole

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.

INDICATIONS

FDA

  • Following fungal infections in immunocompromised and non-immunocompromised patients:
  • Onychomycosis in non-immunocompromised patients (oral capsule):
    • Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
    • Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
  • Oropharyngeal and esophageal candidiasis (oral liquid)
  • Neutropenic fever in patients with suspected fungal infection (oral liquid).

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 3, 2021